HealthStream (HSTM) 10-Q 1 May 14 2014 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2014	Apr. 28, 2014
Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	31-Mar-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'
Entity Registrant Name	'HEALTHSTREAM INC	'
Entity Central Index Key	'0001095565	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	27,564,606

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$59,045	$59,537
Marketable securities	42,952	48,659
Accounts receivable, net of allowance for doubtful accounts of $276 and $211 at March 31, 2014 and December 31, 2013, respectively	32,073	25,314
Accounts receivable -unbilled	1,427	1,392
Prepaid royalties, net of amortization	11,523	8,857
Other prepaid expenses and other current assets	3,231	3,365
Total current assets	150,251	147,124
Property and equipment:	'	'
Equipment	22,163	21,631
Leasehold improvements	5,806	5,521
Furniture and fixtures	4,138	3,854
Property and equipment, gross	32,107	31,006
Less accumulated depreciation and amortization	-22,918	-21,968
Total, property and equipment	9,189	9,038
Capitalized software development, net of accumulated amortization of $14,844 and $13,910 at March 31, 2014 and December 31, 2013, respectively	11,783	11,077
Goodwill	42,749	35,746
Intangible assets, net of accumulated amortization of $11,867 and $11,389 at March 31, 2014 and December 31, 2013, respectively	15,992	8,870
Other assets	995	739
Total assets	230,959	212,594
Current liabilities:	'	'
Accounts payable	2,914	2,311
Accrued royalties	10,907	8,435
Accrued liabilities	6,948	5,503
Accrued compensation and related expenses	1,291	1,614
Deferred tax liabilities, current	181	181
Deferred revenue	47,478	38,168
Total current liabilities	69,719	56,212
Deferred tax liabilities, noncurrent	6,173	6,173
Other long term liabilities	750	776
Commitments and contingencies	'	'
Shareholders' equity:	'	'
Common stock, no par value, 75,000 shares authorized; 27,565 and 27,327 shares issued and outstanding at March 31, 2014 and December 31, 2013, respectively	169,816	166,888
Accumulated deficit	-15,476	-17,424
Accumulated other comprehensive loss	-23	-31
Total shareholders' equity	154,317	149,433
Total liabilities and shareholders' equity	$230,959	$212,594

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Statement Of Financial Position [Abstract]	'	'
Allowance for doubtful accounts, net	$276	$211
Accumulated amortization on capitalized software development	14,844	13,910
Accumulated amortization on intangible assets	$11,867	$11,389
Common stock, no par value	'	'
Common stock, shares authorized	75,000	75,000
Common stock, shares issued	27,565	27,327
Common stock, shares outstanding	27,565	27,327

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Income Statement [Abstract]	'	'
Revenues, net	$38,350	$29,646
Operating costs and expenses:	'	'
Cost of revenues (excluding depreciation and amortization)	16,926	12,520
Product development	3,546	2,606
Sales and marketing	6,947	5,199
Other general and administrative expenses	5,232	4,272
Depreciation and amortization	2,401	1,876
Total operating costs and expenses	35,052	26,473
Income from operations	3,298	3,173
Other income, net	45	47
Income before income tax provision	3,343	3,220
Income tax provision	1,395	1,279
Net income	$1,948	$1,941
Earnings per share:	'	'
Basic	$0.07	$0.07
Diluted	$0.07	$0.07
Weighted average shares of common stock outstanding:	'	'
Basic	27,453	26,340
Diluted	27,906	27,409

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Statement Of Income And Comprehensive Income [Abstract]	'	'
Net income	$1,948	$1,941
Other comprehensive income, net of taxes:	'	'
Unrealized gain (loss) on marketable securities	8	-10
Total other comprehensive income (loss)	8	-10
Comprehensive income	$1,956	$1,931

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY (UNAUDITED) (USD $)	Total	Common Stock [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]
In Thousands
Beginning balance at Dec. 31, 2013	$149,433	$166,888	($17,424)	($31)
Beginning balance, shares at Dec. 31, 2013	'	27,327	'	'
Net income	1,948	'	1,948	'
Comprehensive income	8	'	'	8
Issuance of common stock in acquisition	2,247	2,247	'	'
Issuance of common stock in acquisition, shares	'	82	'	'
Stock based compensation	384	384	'	'
Common stock issued under stock plans, net of shares withheld for employee taxes	297	297	'	'
Common stock issued under stock plans, net of shares withheld for employee taxes, shares	'	156	'	'
Ending balance at Mar. 31, 2014	$154,317	$169,816	($15,476)	($23)
Ending balance, shares at Mar. 31, 2014	'	27,565	'	'

CONDENSED_CONSOLIDATED_STATEME3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
OPERATING ACTIVITIES:	'	'
Net income	$1,948	$1,941
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	2,401	1,876
Stock based compensation expense	384	310
Deferred income taxes	1,395	1,279
Provision for doubtful accounts	70	20
Other	376	308
Changes in operating assets and liabilities:	'	'
Accounts and unbilled receivables	-5,107	-7,487
Prepaid royalties	-2,667	1,652
Other prepaid expenses and other current assets	140	-270
Other assets	26	27
Accounts payable	604	230
Accrued royalties	2,472	-1,477
Accrued liabilities and accrued compensation and related expenses and other long-term liabilities	-1,452	167
Deferred revenue	8,599	5,279
Net cash provided by operating activities	9,189	3,855
INVESTING ACTIVITIES:	'	'
Acquisitions, net of cash acquired	-12,501	-181
Proceeds from maturities of investments in marketable securities	18,517	29,475
Purchases of investments in marketable securities	-13,176	-29,552
Investments in non-marketable equity investments	-250	'
Payments associated with capitalized software development	-1,464	-1,072
Purchases of property and equipment	-1,104	-744
Net cash used in investing activities	-9,978	-2,074
FINANCING ACTIVITIES:	'	'
Proceeds from exercise of stock options	449	900
Taxes paid related to net settlement of equity awards	-152	-158
Net cash provided by financing activities	297	742
Net increase (decrease) in cash and cash equivalents	-492	2,523
Cash and cash equivalents at beginning of period	59,537	41,365
Cash and cash equivalents at end of period	59,045	43,888
NON-CASH INVESTING AND FINANCING ACTIVITIES:	'	'
Issuance of common stock in connection with acquisition	$2,247	'

BASIS_OF_PRESENTATION

BASIS OF PRESENTATION	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
BASIS OF PRESENTATION	'
	1. BASIS OF PRESENTATION
	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (US GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, condensed consolidated financial statements do not include all of the information and footnotes required by US GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. All significant intercompany transactions have been eliminated in consolidation. Operating results for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014.
	The balance sheet at December 31, 2013 is consistent with the audited financial statements at that date but does not include all of the information and footnotes required by US GAAP for a complete set of financial statements. For further information, refer to the consolidated financial statements and footnotes thereto for the year ended December 31, 2013 (included in the Company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 4, 2014).

INCOME_TAXES

INCOME TAXES	3 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
INCOME TAXES	'
	2. INCOME TAXES
	Income taxes are accounted for using the asset and liability method, whereby deferred tax assets and liabilities are determined based on the temporary differences between the financial statement and tax bases of assets and liabilities measured at tax rates that will be in effect for the year in which the differences are expected to affect taxable income.
	During the three months ended March 31, 2014 and 2013, the Company recorded a provision for income taxes of approximately $1.4 million and $1.3 million respectively. The Company’s effective tax rate for the three months ended March 31, 2014 and 2013 was 41.7% and 39.7%, respectively. The Company’s effective tax rate primarily reflects the statutory corporate income tax rate, the net effect of state taxes, and the effect of various permanent tax differences.

STOCK_BASED_COMPENSATION

STOCK BASED COMPENSATION	3 Months Ended
	Mar. 31, 2014
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]	'
STOCK BASED COMPENSATION	'
	3. STOCK BASED COMPENSATION
	The Company maintains two stock incentive plans. The Company accounts for its stock based compensation plans using the fair-value based method for costs related to share-based payments, including stock options and restricted share units (RSUs). During the three months ended March 31, 2014, the Company issued 62,080 RSUs with a weighted average grant date fair value of $29.15 per share, measured based on the closing fair market value of the Company’s stock on the date of grant. During the three months ended March 31, 2013, the Company issued 77,750 RSUs with a weighted average grant date fair value of $21.70 per share, measured based on the closing fair market value of the Company’s stock on the date of grant.
	Total stock based compensation expense recorded for the three months ended March 31, 2014 and 2013, which is recorded in the condensed consolidated statements of income, is as follows (in thousands):
		Three Months Ended
		March 31,
		2014		2013
	Cost of revenues (excluding depreciation and amortization)	$	17	$	16
	Product development		44		34
	Sales and marketing		47		36
	Other general and administrative		276		224
	Total stock based compensation expense	$	384	$	310

EARNINGS_PER_SHARE

EARNINGS PER SHARE	3 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
EARNINGS PER SHARE	'
	4. EARNINGS PER SHARE
	Basic earnings per share is computed by dividing the net income available to common shareholders for the period by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing the net income for the period by the weighted average number of potentially dilutive common and common equivalent shares outstanding during the period. Common equivalent shares are composed of incremental common shares issuable upon the exercise of stock options and restricted share units subject to vesting. The dilutive effect of common equivalent shares is included in diluted earnings per share by application of the treasury stock method. The total number of common equivalent shares excluded from the calculations of diluted earnings per share, due to their anti-dilutive effect, was approximately 165,000 and 135,000 for the three months ended March 31, 2014 and 2013, respectively.
	The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2014 and 2013 (in thousands, except per share data):
		Three Months Ended
		March 31,
		2014		2013
	Numerator:
	Net income	$	1,948	$	1,941
	Denominator:
	Weighted-average shares outstanding		27,453		26,340
	Effect of dilutive shares		453		1,069
	Weighted-average diluted shares		27,906		27,409
	Basic earnings per share	$	0.07	$	0.07
	Diluted earnings per share	$	0.07	$	0.07

MARKETABLE_SECURITIES

MARKETABLE SECURITIES	3 Months Ended
	Mar. 31, 2014
Investments Debt And Equity Securities [Abstract]	'
MARKETABLE SECURITIES	'
	5. MARKETABLE SECURITIES
	At March 31, 2014 and December 31, 2013, the fair value of marketable securities, which were all classified as available for sale, included the following (in thousands):
		March 31, 2014
		Adjusted Cost		Unrealized		Unrealized			Fair Value
				Gains		Losses
	Level 2:
	Certificates of deposit	$	2,262	$	—	$	—		$	2,262
	Corporate debt securities		40,713		3		(26	)		40,690
	Subtotal		42,975		3		(26	)		42,952
	Total	$	42,975	$	3	$	(26	)	$	42,952
		December 31, 2013
		Adjusted Cost		Unrealized		Unrealized			Fair Value
				Gains		Losses
	Level 2:
	Certificates of deposit	$	2,260	$	—	$	—		$	2,260
	Corporate debt securities		46,430		—		(31	)		46,399
	Subtotal		48,690		—		(31	)		48,659
	Total	$	48,690	$	—	$	(31	)	$	48,659
	The carrying amounts reported in the condensed consolidated balance sheet approximate the fair value based on quoted market prices or alternative pricing sources and models utilizing market observable inputs. As of March 31, 2014, the Company does not consider any of its marketable securities to be other than temporarily impaired. During the three months ended March 31, 2014 and 2013, the Company did not reclassify any items out of accumulated other comprehensive income to net income. All investments in marketable securities are classified as a current asset on the balance sheet because the underlying securities mature within one year from the balance sheet date.

BUSINESS_COMBINATION

BUSINESS COMBINATION	3 Months Ended
	Mar. 31, 2014
Business Combinations [Abstract]	'
BUSINESS COMBINATION	'
	6. BUSINESS COMBINATION
	On March 3, 2014, the Company acquired all of the stock of Health Care Compliance Strategies, Inc. (HCCS), a Jericho, New York based company that specializes in healthcare compliance solutions and services. The Company acquired HCCS to further advance its suite of workforce development solutions, including its offering of compliance solutions. The consideration paid for HCCS consisted of approximately $13.0 million in cash and 81,614 shares of our common stock. The Company may make additional payments of up to $750,000, contingent upon the achievement of certain performance milestones within one year post-closing. The Company incurred approximately $500,000 in transaction costs associated with the acquisition, of which $350,000 were incurred during the three months ended March 31, 2014 and $150,000 were incurred during the year ended December 31, 2013. The transaction costs were recorded in other general and administrative expenses in the condensed consolidated statement of income. In allocating the purchase price, the Company has preliminarily recorded approximately $7.0 million of goodwill, $7.6 million of identifiable intangible assets, $2.5 million of tangible assets, and $1.1 million of liabilities. The goodwill balance is primarily attributed to assembled workforce, additional market opportunities of HCCS’s compliance solutions, and expected synergies from integrating HCCS’s products into our platform. The goodwill balance is deductible for U.S. income tax purposes. The allocation of purchase price is preliminary and may be subject to change within the measurement period of one year from the acquisition date. The primary areas of the preliminary purchase price allocation that are not finalized include the composition and valuation of intangible assets, goodwill, deferred revenue, and contingent consideration. The results of operations for HCCS have been included in the Company’s condensed consolidated financial statements from the date of acquisition, and are also included in the HealthStream Workforce Development Solutions segment.

BUSINESS_SEGMENTS

BUSINESS SEGMENTS	3 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
BUSINESS SEGMENTS	'
	7. BUSINESS SEGMENTS
	The Company primarily provides services to healthcare organizations and other members within the healthcare industry. The Company’s services are primarily focused on the delivery of workforce development products and services (HealthStream Workforce Development Solutions), as well as survey and research services (HealthStream Research/Patient Experience Solutions). The accounting policies of the segments are the same as those described in the summary of significant accounting policies in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.
	The Company measures segment performance based on operating income before income taxes and prior to the allocation of certain corporate overhead expenses, interest income, interest expense, and depreciation. The Unallocated component below includes corporate functions, such as accounting, human resources, legal, investor relations, administrative, and executive personnel, depreciation, a portion of amortization, and certain other expenses, which are not currently allocated in measuring segment performance. The following is the Company’s business segment information as of and for the three months ended March 31, 2014 and 2013 (in thousands).
			Three Months Ended
			March 31,
			2014			2013
	Revenues
	Workforce Development		$	30,957		$	23,140
	Research/Patient Experience			7,393			6,506
	Total net revenue		$	38,350		$	29,646
			Three Months Ended
			March 31,
			2014			2013
	Income from operations
	Workforce Development		$	7,880		$	6,816
	Research/Patient Experience			178			301
	Unallocated			(4,760	)		(3,944	)
	Total income from operations		$	3,298		$	3,173
			March 31,			December 31,
			2014			2013
	Segment assets*
	Workforce Development		$	84,857		$	60,013
	Research/Patient Experience			34,092			34,727
	Unallocated			112,010			117,854
	Total assets		$	230,959		$	212,594
	*	Segment assets include accounts and unbilled receivables, prepaid and other current assets, other assets, capitalized software development, certain property and equipment, and intangible assets. Cash and cash equivalents and marketable securities are not allocated to individual segments, and are included within Unallocated. A significant portion of property and equipment assets are included within Unallocated.

COLLABORATIVE_ARRANGEMENT

COLLABORATIVE ARRANGEMENT	3 Months Ended
	Mar. 31, 2014
Organization Consolidation And Presentation Of Financial Statements [Abstract]	'
COLLABORATIVE ARRANGEMENT	'
	8. COLLABORATIVE ARRANGEMENT
	The Company participates in a collaborative arrangement, SimVenturesTM, with Laerdal Medical A/S (Laerdal Medical). The Company receives 50 percent of the profits or losses generated from this collaborative arrangement. For the three months ended March 31, 2014, the Company has recorded approximately $0.4 million of revenues and $0.5 million of expenses related to the collaborative arrangement. For the three months ended March 31, 2013, the Company recorded approximately $0.4 million of revenues and $0.4 million of expenses related to the collaborative arrangement. The Company has also recorded approximately $0.2 million of capitalized software development for SimVentures during 2014.

STOCK_BASED_COMPENSATION_Table

STOCK BASED COMPENSATION (Tables)	3 Months Ended
	Mar. 31, 2014
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]	'
Stock Based Compensation Expense Recorded in Condensed Consolidated Statements of Income	'
	Total stock based compensation expense recorded for the three months ended March 31, 2014 and 2013, which is recorded in the condensed consolidated statements of income, is as follows (in thousands):
		Three Months Ended
		March 31,
		2014		2013
	Cost of revenues (excluding depreciation and amortization)	$	17	$	16
	Product development		44		34
	Sales and marketing		47		36
	Other general and administrative		276		224
	Total stock based compensation expense	$	384	$	310

EARNINGS_PER_SHARE_Tables

EARNINGS PER SHARE (Tables)	3 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Computation of Basic and Diluted Earnings Per Share	'
	The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2014 and 2013 (in thousands, except per share data):
		Three Months Ended
		March 31,
		2014		2013
	Numerator:
	Net income	$	1,948	$	1,941
	Denominator:
	Weighted-average shares outstanding		27,453		26,340
	Effect of dilutive shares		453		1,069
	Weighted-average diluted shares		27,906		27,409
	Basic earnings per share	$	0.07	$	0.07
	Diluted earnings per share	$	0.07	$	0.07

MARKETABLE_SECURITIES_Tables

MARKETABLE SECURITIES (Tables)	3 Months Ended
	Mar. 31, 2014
Investments Debt And Equity Securities [Abstract]	'
Fair Value of Available for Sale Marketable Securities	'
	At March 31, 2014 and December 31, 2013, the fair value of marketable securities, which were all classified as available for sale, included the following (in thousands):
		March 31, 2014
		Adjusted Cost		Unrealized		Unrealized			Fair Value
				Gains		Losses
	Level 2:
	Certificates of deposit	$	2,262	$	—	$	—		$	2,262
	Corporate debt securities		40,713		3		(26	)		40,690
	Subtotal		42,975		3		(26	)		42,952
	Total	$	42,975	$	3	$	(26	)	$	42,952
		December 31, 2013
		Adjusted Cost		Unrealized		Unrealized			Fair Value
				Gains		Losses
	Level 2:
	Certificates of deposit	$	2,260	$	—	$	—		$	2,260
	Corporate debt securities		46,430		—		(31	)		46,399
	Subtotal		48,690		—		(31	)		48,659
	Total	$	48,690	$	—	$	(31	)	$	48,659

BUSINESS_SEGMENTS_Tables

BUSINESS SEGMENTS (Tables)	3 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
Business Segment Information Based on Net Revenues and Net Income from Operations	'
	The following is the Company’s business segment information as of and for the three months ended March 31, 2014 and 2013 (in thousands).
			Three Months Ended
			March 31,
			2014			2013
	Revenues
	Workforce Development		$	30,957		$	23,140
	Research/Patient Experience			7,393			6,506
	Total net revenue		$	38,350		$	29,646
			Three Months Ended
			March 31,
			2014			2013
	Income from operations
	Workforce Development		$	7,880		$	6,816
	Research/Patient Experience			178			301
	Unallocated			(4,760	)		(3,944	)
	Total income from operations		$	3,298		$	3,173
Business Segment Information Based on Assets	'
			March 31, 2014			December 31, 2013
	Segment assets *
	Workforce Development		$	84,857		$	60,013
	Research/Patient Experience			34,092			34,727
	Unallocated			112,010			117,854
	Total assets		$	230,959		$	212,594
	*	Segment assets include accounts and unbilled receivables, prepaid and other current assets, other assets, capitalized software development, certain property and equipment, and intangible assets. Cash and cash equivalents and marketable securities are not allocated to individual segments, and are included within Unallocated. A significant portion of property and equipment assets are included within Unallocated.

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Income Tax Disclosure [Abstract]	'	'
Income tax provision	$1,395	$1,279
Effective tax rate	41.70%	39.70%

Stock_Based_Compensation_Addit

Stock Based Compensation - Additional Information (Detail) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of incentive plans	2	'
RSUs [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Restricted share units issued	62,080	77,750
Weighted average grant date fair value, restricted share unit	$29.15	$21.70

Stock_Based_Compensation_Stock

Stock Based Compensation - Stock Based Compensation Expense Recorded in Condensed Consolidated Statements of Income (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Total stock based compensation expense	$384	$310
Cost of Revenues (Excluding Depreciation and Amortization) [Member]	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Total stock based compensation expense	17	16
Product Development [Member]	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Total stock based compensation expense	44	34
Sales and Marketing [Member]	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Total stock based compensation expense	47	36
Other General and Administrative [Member]	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Total stock based compensation expense	$276	$224

Earnings_Per_Share_Additional_

Earnings Per Share - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Earnings Per Share [Abstract]	'	'
Total number of common equivalent shares excluded from the calculations of diluted earnings per share	165,000	135,000

Earnings_Per_Share_Computation

Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Detail) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Numerator:	'	'
Net income	$1,948	$1,941
Denominator:	'	'
Weighted-average shares outstanding	27,453	26,340
Effect of dilutive shares	453	1,069
Weighted-average diluted shares	27,906	27,409
Basic earnings per share	$0.07	$0.07
Diluted earnings per share	$0.07	$0.07

Marketable_Securities_Fair_Val

Marketable Securities - Fair Value of Available for Sale Marketable Securities (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Schedule of Available-for-sale Securities [Line Items]	'	'
Available for sale securities, Fair Value	$42,952	$48,659
Level 2 [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Available for sale securities, Adjusted Cost	42,975	48,690
Available for sale securities, Unrealized Gains	3	'
Available for sale securities, Unrealized Losses	-26	-31
Available for sale securities, Fair Value	42,952	48,659
Level 2 [Member] | Certificates of Deposit [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Available for sale securities, Adjusted Cost	2,262	2,260
Available for sale securities, Unrealized Gains	'	'
Available for sale securities, Unrealized Losses	'	'
Available for sale securities, Fair Value	2,262	2,260
Level 2 [Member] | Corporate Debt Securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Available for sale securities, Adjusted Cost	40,713	46,430
Available for sale securities, Unrealized Gains	3	'
Available for sale securities, Unrealized Losses	-26	-31
Available for sale securities, Fair Value	$40,690	$46,399

Business_Combination_Additiona

Business Combination - Additional Information (Detail) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Business Acquisition [Line Items]	'	'
Purchase price allocation for goodwill	$42,749,000	$35,746,000
Health Care Compliance Strategies, Inc. [Member]	'	'
Business Acquisition [Line Items]	'	'
Acquisition date of assets	3-Mar-14	'
Consideration paid for acquisition in cash	13,000,000	'
Consideration paid for acquisition in shares	81,614	'
Additional consideration paid for acquisition in cash	750,000	'
Contingent upon achievement of certain financial targets and business outcome, term	'1 year	'
Transaction costs associated with the HCCS acquisition	500,000	'
Transaction costs associated with the HCCS acquisition	350,000	150,000
Purchase price allocation for goodwill	7,000,000	'
Purchase price allocation for identifiable intangible assets	7,600,000	'
Purchase price allocation for net tangible assets	2,500,000	'
Purchase price allocation for liabilities	$1,100,000	'
Preliminary purchase price allocation measurement period	'1 year	'

Business_Segments_Business_Seg

Business Segments - Business Segment Information Based on Net Revenues and Net Income from Operations (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Revenues	'	'
Total net revenue	$38,350	$29,646
Income from operations	'	'
Total income from operations	3,298	3,173
Operating Segments [Member] | Workforce Development [Member]	'	'
Revenues	'	'
Total net revenue	30,957	23,140
Income from operations	'	'
Total income from operations	7,880	6,816
Operating Segments [Member] | Research/Patient Experience [Member]	'	'
Revenues	'	'
Total net revenue	7,393	6,506
Income from operations	'	'
Total income from operations	178	301
Unallocated [Member]	'	'
Income from operations	'	'
Total income from operations	($4,760)	($3,944)

Business_Segments_Business_Seg1

Business Segments - Business Segment Information Based on Assets (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Segment Reporting Information [Line Items]	'	'
Total assets	$230,959	$212,594
Operating Segments [Member] | Workforce Development [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Total assets	84,857	60,013
Operating Segments [Member] | Research/Patient Experience [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Total assets	34,092	34,727
Unallocated [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Total assets	$112,010	$117,854

Collaborative_Arrangement_Addi

Collaborative Arrangement - Additional Information (Detail) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]	'	'
Profits or losses received from collaborative arrangement	50.00%	'
Revenues related to collaborative arrangement	$400,000	$400,000
Expenses related to collaborative arrangement	500,000	400,000
Payments associated with capitalized software development	1,464,000	1,072,000
SimVentures [Member]	'	'
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]	'	'
Payments associated with capitalized software development	$200,000	'